Robin Wright
Net worth: 32 862 $ as of 2026-05-30
Net worth: 32 862 $ as of 2026-05-30
Robin Wright currently works at Barinthus Biotherapeutics (UK) Ltd., as Chairman, Barinthus Biotherapeutics Plc, as Chairman from 2018, KDev Investments AB, as Director, and The Institute of Chartered Accountants in England & Wales, as Fellow.
Mr. Wright also formerly worked at Pharming Group NV, as Chief Financial Officer from 2015 to 2020, Orexo AB, as CFO & Head-Business Development from 2008 to 2011, and Karolinska Development AB (Private Equity), as Chief Financial Officer from 2011 to 2014.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-04 | 48,256 ( 0.12% ) | 32 862 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chairman | 2018-09-30 |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Director/Board Member | - |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Chairman | - |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| PHARMING GROUP N.V. | Director of Finance/CFO | 2020-05-19 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Director of Finance/CFO | 2014-02-27 |
| OREXO AB | Director of Finance/CFO | 2011-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Vaccitech Plc
Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions